Skip to main content
Allopurinol CAS#: 315-30-0
IdentificationPhysical DataSpectraRoute of Synthesis (ROS)Safety and HazardsOther Data

Identification

Product NameAllopurinol IUPAC Name1,5-dihydropyrazolopyrimidin-4-oneMolecular StructureCAS Registry Number 315-30-0EINECS Number206-250-9MDL NumberMFCD00599413Synonymsallopurinol315-30-01H-Pyrazolopyrimidin-4-olZyloprimLopurinZyloricSuspendolAtisurilBleminolCaplenalTakanaruminUripurinolEmbarin4-Hydroxypyrazolopyrimidine1H-Pyrazolopyrimidin-4(5H)-oneAllopurinolum1H-Pyrazolo(3,4-d)pyrimidin-4-ol4-Hydroxypyrazolopyrimidine4-Hydroxy-1H-pyrazolo(3,4-d)pyrimidine1H-pyrazolopyrimidin-4(7H)-one4-Hydroxy-3,4-pyrazolopyrimidine4-Hydroxypyrazolo(3,4-d)pyrimidineAlopurinol Allopurinolum 2H-Pyrazolopyrimidin-4-ol1H-pyrazolopyrimidin-4(2H)-one4-Hydroxypyrazolyl(3,4-d)pyrimidine4H-Pyrazolo(3,4-d)pyrimidin-4-one4'-Hydroxypyrazolol(3,4-d)pyrimidine180749-09-11,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one1,5-Dihydro-4H-pyrazolopyrimidin-4-one1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidine-4-one4H-Pyrazolo(3,4-d)pyrimidin-4-one, 1,5-dihydro-4H-Pyrazolopyrimidin-4-one, 1,5-dihydro-1,5-Dihydropyrazolopyrimidin-4-oneMFCD00599413HSDB 3004EINECS 206-250-9UNII-63CZ7GJN5INSC-10165563CZ7GJN5ISMR0000590834-Hydroxy-1H-pyrazolopyrimidineALLOPURINOL SODIUMATH0081H-Pyrazolopyrimidin-4-ol (9CI)4H-Pyrazolopyrimidin-4-one, 1,7-dihydro- (9CI)1H,2H,4H-pyrazolopyrimidin-4-one1H,4H,7H-pyrazolopyrimidin-4-oneDTXSID4022573NSC1390Allopurinol 4H-Pyrazolopyrimidin-4-one, 1,2-dihydro-NSC1016559002-17-9Allopurinol NCGC00015094-02NCGC00094580-044H-Pyrazolopyrimidin-4-one, 2,5-dihydro- (9CI)4H-Pyrazolopyrimidin-4-one, 2,7-dihydro- (9CI)AllohexalBW 56158BW-561581H,4H,5H-pyrazolopyrimidin-4-one1,5-Dihydro-pyrazolopyrimidin-4-oneA 8003DTXCID5025734H-PyrazolopyrimidinePan Quimica4'-HydroxypyrazololpyrimidineCAS-315-30-0SR-05000001983HexanuratUrictoQuimica, PanAllohexal (TN)4-HydroxypyrazolpyrimidinePrestwick_511Xanthomax-100Xanthomax-3004H-Pyrazolopyrimidin-4-one,1,2-dihydro-Zyloric-300Allopurinol (Zyloprim)Spectrum_000026ALLOPURINOL Opera_ID_1680Lopac-A-80031,4-d]pyrimidin-4-oneSCHEMBL4627ALLOPURINOL CHEMBL1467NCIOpen2_001825Lopac0_000102ALLOPURINOL ALLOPURINOL ALLOPURINOL BSPBio_001798KBioGR_000550KBioSS_000386MLS001148183US9138393, AllopurinolUS9144538, AllopurinolDivK1c_000685SPECTRUM1500108SPBio_000056ALLOPURINOLUM GTPL6795SCHEMBL1128219Allopurinol (JP17/USP/INN)BDBM35440HMS502C07KBio1_000685KBio2_000386KBio2_002954KBio2_005522KBio3_001298ALLOPURINOL ALLOPURINOL NINDS_000685ALLOPURINOL BDBM181133HMS1920A15Pharmakon1600-01500108ALLOPURINOL Allopurinol AMY18272BCP26973DRG-0056DUZALLO COMPONENT ALLOPURINOLH-Pyrazolo(3,4-d)pyrimidin-4-olHY-B0219STR05189Tox21_1100824-Hydroxy-pyrazolopyrimidinAC-019BBL009959BDBM50016784BDBM50140241CCG-38916NSC755858s1630SC1118SC2251STK378584STK711106AKOS000267490Tox21_110082_1Allopurinol, xanthine oxidase inhibitorTS-00028SBI-0050090.P0042H-Pyrazolopyrimidin-4-ol (9CI)A0907EU-0100102SW199406-41,5-dihydropyrazolo-pyrimidin-4-oneEN300-34144VU0611037-1BIM-0061756.00014h-pyrazolopyrimidin-4-one,1,7-dihydro-AB-323/25048497Allopurinol (4-Hydroxypyrazolopyrimidine)Q412486SR-010000755951,5-Dihydro-4H-pyrazolo-nupyrimidin-4-one4H-pyrazolopyrimidin-4-one, 1,7-dihydro-J-504736SR-01000075595-1SR-05000001983-1SR-05000001983-2W-1068924H-pirazolo pirimidina-4-ona, 1,5-dihidro-F2173-0394F3329-0375Z104486670Allopurinol, British Pharmacopoeia (BP) Reference StandardAllopurinol, European Pharmacopoeia (EP) Reference StandardAllopurinol, United States Pharmacopeia (USP) Reference Standard1,5-Dihydro-4H-pyrazolopyrimidin-4-one Synonym: AllopurinolAllopurinol, Pharmaceutical Secondary Standard; Certified Reference Material1H-Pyrazolopyrimidin-4-ol;1H-PYRAZOLOPYRIMIDIN-4(5H)-ONE184856-42-6Molecular FormulaC5H4N4OMolecular Weight136.11InChIInChI=1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10)InChI KeyOFCNXPDARWKPPY-UHFFFAOYSA-NCanonical SMILESC1=NNC2=C1C(=O)NC=N2  

Patent InformationPatent IDTitlePublication DateUS2001/53373Process and device for producing liquid dosage formulations of medicinal compounds on demand from tablets and capsules2001

Physical Data

AppearanceOff-white powder

Melting Point, °C 350 - 360350297 - 299

Description (Association (MCS))Solvent (Association (MCS))Temperature (Association (MCS)), °CPartner (Association (MCS))AdsorptionH2O, HCl37cross-linked insoluble polyvinylpyrrolidoneChemisorptionH2O37cross-linked insoluble polyvinylpyrrolidoneChemisorptionH2O, HCl37cross-linked insoluble polyvinylpyrrolidone

Spectra

Description (IR Spectroscopy)Spectrum

Description (UV/VIS Spectroscopy)Solvent (UV/VIS Spectroscopy)Comment (UV/VIS Spectroscopy)Absorption Maxima (UV/VIS), nmSpectrum210 - 330 nmSpectrumH2O200 - 280 nmAbsorption maximaH2O251SpectrumH2O240 - 280 nm

Route of Synthesis (ROS)

Route of Synthesis (ROS) of Allopurinol CAS#: 315-30-0

ConditionsYieldWith N,N-dimethyl-formamide; trichlorophosphate for 12h; Reflux;76%With trichlorophosphate In N,N-dimethyl-aniline for 1h; Reflux;72%With trichlorophosphate In N,N-dimethyl-aniline at 80℃; for 2h;Experimental ProcedureA mixture of allopurinol (2.00 g, 14.69 mmol) and N,N-dimethylaniline (2.00 g, 16.52 mmol) wasstirred in POCl3 (25 mL) at 80 °C for 2 h. The reaction mixture was diluted with water (35 mL), andextracted with ethyl acetate. The organic layer was washed with water and the organic phase wasconcentrated to dryness, and the residue was purified by column chromatography on silica gel using4:1.5 petroleum ether/ethyl acetate as eluent to give 2; white flake solid, 70 % yield.70%

Safety and Hazards

No data available

Other Data

TransportationUnder room temperature away from lightHS CodeStorageUnder room temperature away from lightShelf Life5 yearsMarket Price

DruglikenessLipinski rules componentMolecular Weight136.113logP0.905HBA4HBD2Matching Lipinski Rules4Veber rules componentPolar Surface Area (PSA)74.69Rotatable Bond (RotB)0Matching Veber Rules2

Quantitative Results1 of 800Comment (Pharmacological Data)Bioactivities presentReferenceCompositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress2 of 800Comment (Pharmacological Data)Bioactivities presentReferenceFUSED BICYCLIC NATURAL COMPOUNDS AND THEIR USE AS INHIBITORS OF PARP AND PARP-MEDIATED INFLAMMATORY PROCESSES3 of 800Comment (Pharmacological Data)Bioactivities presentReferencePROTEIN KINASE C ZETA INHIBITION TO TREAT VASCULAR PERMEABILITY

Use PatternAllopurinol CAS#: 315-30-0 is an intermediate in pesticides and dyes; pesticide raw materials; analytical reagents.
https://www.chemwhat.com/allopurinol-cas-315-30-0-2/

Comments

Post a Comment

Popular posts from this blog

Overcoming the "Choke Points" in Semaglutide Side Chain Synthesis with Core Technologies to Enable Efficient GLP-1 Drug Manufacturing

Semaglutide, a groundbreaking product in the GLP-1 drug class, owes its extended half-life and enhanced receptor affinity largely to its unique side chain, Ste-Glu-AEEA-AEEA-OSU (CAS: 1169630-40-3) . This side chain covalently modifies the peptide backbone, significantly improving pharmacokinetics and therapeutic performance. However, its complex structure presents two critical synthetic challenges: Precise Assembly of Repetitive AEEA Units: The side chain features consecutive AEEA (aminoethoxyethoxyacetic acid) units, which require stepwise coupling via highly activated intermediates (e.g., AEEA-AEEA). Any impurities or deviations compromise downstream reaction efficiency and may trigger irreversible byproducts. Stereochemistry and Stability of Glutamic Acid (Glu): The glutamic acid component must maintain strict L-configuration, and its carboxyl groups require directional protection (e.g., OtBu) to preserve biological activity. Leveraging deep expertise in peptide chemistry a...
Post a Comment
Read more
IdentificationPhysical DataSpectraRoute of Synthesis (ROS)Safety and HazardsOther Data Identification Product NameBCTA-4NH2IUPAC NameMolecular StructureCAS Registry Number 2559708-42-6Synonyms4,4',4",4"'-(-3,3',6,6'-tetrayl)tetraanilineMolecular FormulaC48H36N6Molecular Weight696.86 Physical Data AppearanceYellow to white powder Spectra No data available BCTA-4NH2 CAS#：2559708-42-6 NMR Route of Synthesis (ROS) No data available Safety and Hazards No data available Other Data TransportationStore at 2-8°C away from light for long time storageStore at 2-8°C away from light for long time storageHS CodeStorageStore at 2-8°C away from light for long time storageShelf Life1 yearMarket Price Toxicity/Safety PharmacologyQuantitative Results Use PatternBCTA-4NH2 CAS#: 2559708-42-6 is an organic compound with a wide range of applications. One of its primary uses is in the field of organic electronics, where it is used as a hole-transport material in organic light-emitti...
Post a Comment
Read more

Watson Chem: Pioneering Advanced Semiconductor Materials for a Sustainable Future

In today’s rapidly advancing technological landscape, the innovation of materials science is driving progress across various high-tech sectors. As a R&D platform of Watson International, Watson Chem has positioned itself at the forefront of semiconductor materials development, becoming a trusted partner for leading global research institutions, energy companies, and high-tech firms. By focusing on extreme purity and stability, Watson Chem specializes in creating cutting-edge semiconductor materials that underpin the breakthrough technologies of tomorrow. Core Competency: Extreme Purity and Stability Watson Chem’s semiconductor materials encompass a range of ultra-pure elements, oxides, sulfides, tellurides, selenides, antimonides, and other semiconductor compounds, available in purity levels ranging from 3N to 7N and beyond. These materials meet the stringent requirements of the most advanced research fields, providing the solid foundation needed for breakthrough innovations. Tru...
Post a Comment
Read more